ARP39721_T100
antibody from Aviva Systems Biology
Targeting: RIOX2
FLJ14393, JMJD10, mdig, MINA, MINA53, NO52
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ARP39721_T100 - Provider product page
- Provider
- Aviva Systems Biology
- Proper citation
- Aviva Systems Biology Cat#ARP39721_T100, RRID:AB_841551
- Product name
- MINA antibody - N-terminal region (ARP39721_T100)
- Antibody type
- Polyclonal
- Antigen
- The immunogen is a synthetic peptide directed towards the N terminal region of human MINA
- Description
- Protein A purified
- Reactivity
- Human, Rat, Horse, Porcine, Rabbit
- Host
- Rabbit
- Vial size
- 100 μl
- Concentration
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
- Storage
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- WB Suggested Anti-MINA Antibody Titration: 0.25ug/ml, ELISA Titer: 1:62500, Positive Control: Human Thymus
- Sample type
- Human Thymus
- Primary Ab dilution
- 4-8 µg/mL
- Protocol
- Protocol
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Immunohistochemistry staining of Human Intestine with Anti-MINA antibody
- Sample type
- Human Intestine
- Validation comment
- This location is supported by literature
- Primary Ab dilution
- 4.0-8.5252
- Secondary Ab
- Secondary Ab
- Secondary Ab dilution
- 0.5ug/mL 0.2ug/mL
- Protocol
- Protocol
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Immunohistochemistry with Human Intestine tissue at an antibody concentration of 4-8µg/ml using anti-MINA antibody (ARP39721_T100)
- Sample type
- Human Intestine
- Primary Ab dilution
- 0.25 µg/mL
- Protocol
- Protocol